by CommonWealth Beacon | Feb 14, 2025
Greater Boston’s acclaimed universities, hospitals, and affiliated research institutions are the fuel that made the region a juggernaut of the 21st-century knowledge economy. Now they are making it a target.
by Banker & Tradesman | Sep 29, 2024
Despite the spring’s bad headlines, this summer ended with a pile of venture capital deals and two more Bay State biotech IPOs. It’s time for Beacon Hill to do its part to keep that momentum going.
by Banker & Tradesman | Sep 29, 2024
The life sciences and lab market across the Boston metro area has been in a state of flux for some time, but a new factors have added extra pressure on landlords and owners.
by Steve Adams | Jun 7, 2024
A biotech company founded in 2021 at Harvard’s Wyss Institute is establishing its first dedicated headquarters at Cummings Properties’ campus in Medford.
by Steve Adams | Mar 4, 2024
Takeda Pharmaceutical Co. inked a 10-year lease extension at its 222,025-square-foot R&D center in Cambridge’s Kendall Square.
by Steve Adams | Feb 29, 2024
A developer’s speculative bet on Somerville’s Brickbottom as a new life science industry cluster gained momentum with a 76,000-square-foot lease to Cambridge-based ADA Forsyth Institute.
by Steve Adams | Feb 21, 2024
A speculative lab project in Waltham landed its largest tenant to date in a Framingham-based biopharma company.
by Steve Adams | Jan 15, 2024
Downsizing in the local life science industry sent ripples through the Greater Boston lab market in 2023, resulting in its worst performance since 2009.
by Steve Adams | Dec 17, 2023
Transformative projects reshaping the Dorchester waterfront and streets surrounding Fenway Park cleared their biggest hurdles at Boston City Hall in 2023, but a challenging development climate points to a reduced presence of cranes on the skyline.
by Steve Adams | Dec 15, 2023
Alexandria Real Estate Equities’ Waltham life science campus inked a 165,940-square-foot lease with a Danish health care company.
by Steve Adams | Oct 29, 2023
The life science industry is well-known for its tendency to cluster in preferred real estate submarkets. So why would biotechs take a flier on a 65-year-old former newspaper building a 30-minute subway ride from Kendall Square?
by Steve Adams | Oct 11, 2023
Double-digit availability rates are the new norm for lab space in Greater Boston, with only the industry hub of East Cambridge avoiding the full force of the market downturn.
by Steve Adams | Aug 31, 2023
As brokerages compete for a share of shrinking demand for life science space, JLL Boston boosted its life science brokerage team with the addition of a top Cushman & Wakefield executive.
by Steve Adams | Aug 10, 2023
As life science companies retreat to established industry clusters in 2023, a new East Cambridge project landed a 62,000-square-foot lease for a new office, lab and incubator space.
by Steve Adams | Jul 30, 2023
As life science demand wanes, developers are increasingly marketing new projects to Massachusetts’ growing clean energy sector, flush with funding from venture capital and new federal programs.
by Steve Adams | Jul 7, 2023
Demand for life science space declined in the second quarter as the lab vacancy rate in Greater Boston hit 14.3 percent, according to a brokerage report.
by Steve Adams | Jun 26, 2023
A 345,000-square-foot life science development in Lexington is being delayed because of declining industry demand and inflation.
by Steve Adams | Mar 7, 2023
On the heels of recent life science leases reshaping its Cambridgeside property, owner New England Development is set to update Lechmere Canal Park with new lighting, landscaping and accessibility upgrades.
by Steve Adams | Mar 2, 2023
SmartLabs will open its fifth and largest Greater Boston location at the Cambridgeside property as developers reposition the mall property for life science tenants.
by Steve Adams | Feb 2, 2023
The pending reopening of a new observatory at the Prudential Tower is attracting widespread interest as Boston’s newest location for private events with commanding views, Boston Properties executives said.